GAVA: spectral simulation for in vivo MRS applications.

GAVA: spectral simulation for in vivo MRS applications. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

GAVA: spectral simulation for in vivo MRS applications. Abstract Text:

Brian J Soher,Karl Young,Aaron Bernstein,Zakaria Aygula,Andrew A Maudsley,

An application that provides a flexible and easy to use interface to the GAMMA spectral simulation package is described that is targeted at investigations using in vivo MR spectroscopic methods. The program makes available a number of widely used spatially localized MRS pulse sequences and NMR parameters for commonly observed tissue metabolites, enabling spectra to be simulated for any pulse sequence parameter and viewed in an integrated display. The application is interfaced with a database for storage of all simulation parameters and results of the simulations. This application provides a convenient method for generating a priori spectral information used in parametric spectral analyses and for visual examination of the effects of difference pulse sequences and parameter settings.

GAVA: spectral simulation for in vivo MRS applications. Publishing Authors By Initials

BJ Soher,K Young,A Bernstein,Z Aygula,AA Maudsley,

For similar information science: computing methodologies: software: user-computer interface research abstracts see: information science: computing methodologies: software: user-computer interface research

PUBMED ID PMID:

MEDLINE DATE:

GAVA: spectral simulation for in vivo MRS applications. Journal Published:

PUBLICATION TYPE: Research Support, N.I.H., Extr

Journal: Journal of magnetic resonance (San Diego, Calif. :

VOLUME: 185

Page Numbers: 291-9

Journal Abbreviation:

ISSN: 1090-7807

DAY: 12

MONTH: 01

YEAR: 2007

GAVA: spectral simulation for in vivo MRS applications. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9707935

GAVA: spectral simulation for in vivo MRS applications. Keywords Mesh Terms:

KEYWORDS: User-Computer Interface

MESH TERMS: methods

Chemical & Substance for Abstract: GAVA: spectral simulation for in vivo MRS applications. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for GAVA: spectral simulation for in vivo MRS applications.

AFFILIATION: Department of Radiology, Duke University Medical Center, Box 3808, Durham, NC 27710, USA. brian.soher@duke.edu

Country: United States

AGENCY: United States NIBIB

GRANT: R01EB00207

ACRONYM: EB

MEDLINETA: J Magn Reson

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

GAVA: spectral simulation for in vivo MRS applications Related Publications

• A case of myositis ossificans progressiva.
• A functional outpatient desk.
• Assessment of international medical graduates and their integration into family practice: the clinician assessment for practice program.
• Caloric restriction: Impact upon pituitary function and reproduction.
• Can MR spectroscopy ever be simple and effective?
• Charcot joints in diabetic neuropathy.
• Cytoskeletal reorganization dependence of signaling by the gonadotropin-releasing hormone receptor.
• Dysplasia epiphysialis multiplex; a report of fourteen cases in three families.
• Fatigue fractures of the lower tibia; a report of five cases.
• GAVA: spectral simulation for in vivo MRS applications.
• GnRH-mediated DAN production regulates the transcription of the GnRH receptor in gonadotrope cells.
• Gonadotropin-releasing hormone receptors.
• Gonadotropin-releasing hormone-induced activation of diacylglycerol kinase-zeta and its association with active c-src.
• Henery fitzgerald MAUDSLEY.
• Improved reconstruction for MR spectroscopic imaging.
• Instillation-suction technique in chronic osteomyelitis.
• Lightning accident at Ascot.
• Proceedings: Post-operative gas gangrene managed by hyperbaric oxygen.
• Radial tunnel syndrome: resistant tennis elbow as a nerve entrapment.
• Some ideals for a psychiatric service.
• Targeting TNF-alpha receptors for neurotherapeutics.
• The management of gas gangrene with hyperbaric oxygen therapy.
• Therapeutic perspectives for the treatment of Huntington's disease: treating the whole body.
• iTRAQ Analysis of Complex Proteome Alterations in 3xTgAD Alzheimer's Mice: Understanding the Interface between Physiology and Disease.